Legal & General Group Plc Increases Stake in Eli Lilly

Institutional investor boosts ownership in pharmaceutical giant by 3%

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Legal & General Group Plc, a major institutional investor, has increased its holdings in Eli Lilly and Company by 3% in the third quarter, according to a recent SEC filing. The firm now owns 5,383,999 shares of the pharmaceutical company's stock, making it one of Eli Lilly's largest shareholders.

Why it matters

Eli Lilly is one of the world's leading pharmaceutical companies, known for developing innovative drugs and therapies. Legal & General's increased stake signals confidence in the company's long-term growth potential and ability to deliver returns for investors.

The details

According to the SEC filing, Legal & General Group Plc purchased an additional 154,714 shares of Eli Lilly, bringing its total ownership to approximately 0.57% of the company. The institutional investor cited Eli Lilly's strong pipeline of new products and robust financial performance as factors behind the increased investment.

Legal & General Group Plc filed the SEC report in the third quarter of 2026.

The players